- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
Dr. Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals is interviewed by RedChip at NobleCon21 - Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL The post Dr. Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals interview by RedChip at NobleCon21 – Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference appeared first on NRx Pharmaceuticals.
Dr. Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals presents at NobleCon21 - Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference The post Dr. Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals presents at NobleCon21 – Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference appeared first on NRx Pharmaceuticals.
Dr. Jonathan Javitt, CEO of NRx Pharmaceuticals, and Anne Dunsmore, Founder of Angel Force USA, discuss their joint mission to prevent veteran suicide through advanced neuroplastic therapies and nationwide awareness programs. The post Ending Veteran Suicide with Neuroplastic Therapies – NRx & Angel Force USA appeared first on NRx Pharmaceuticals.
Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals, presents at Noble Capital Markets Virtual Emerging Growth Conference. The post Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals, presents at Noble Capital Markets Virtual Emerging Growth Conference appeared first on NRx Pharmaceuticals.
Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares. AdvisorShares is an institutional investor and holder of NRXP stock. The post Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares. appeared first on NRx Pharmaceuticals.
Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares. AdvisorShares is an institutional investor and holder of NRXP stock. The post Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares. appeared first on NRx Pharmaceuticals.
Interview discusses NRx Pharmaceuticals' game-changing approach to mental health treatment. The post Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by New to The Street TV. appeared first on NRx Pharmaceuticals.
Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares. AdvisorShares is an institutional investor and holder of NRXP stock. The post Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares. appeared first on NRx Pharmaceuticals.
NRX-100 is an IV ketamine formulation being submitted to regulators as an alternative treatment for acute suicidal crises in certain types of depression. The post NRX-100’s Breakthrough in Suicidality Treatment appeared first on NRx Pharmaceuticals.
Kadima Neuropsychiatry Institute, featured in the documentary (begins around the 24 minute mark of the documentary), has been identified as a planned HOPE Flagship Clinic acquisition. The post Matthew Perry: A Hollywood Tragedy is a new documentary on how the Friends star died in 2023 appeared first on NRx Pharmaceuticals.
